What strategies would you use if you represented a pharmaceutical company negotiating a licensing agreement with a researcher who had found the next big pediatric AIDS drug? How would your approach change if you represented the researcher?
Students negotiated this intellectual property scenario, among others, at the ABA Law Student Division Negotiation Competition National Finals on February 11–12, at the ABA Midyear Meeting in Atlanta.
